Remove Data Remove Hemp Remove Sleep Remove THC
article thumbnail

Wearables data: CBD+CBN+THC can support deeper sleep

The Cannigma

We know sleep is important. And while research suggests that we’re meant to get at least 7-8 hours a day to function at our best, many around the globe still aren’t getting enough sleep. Participants also found it easier and easier to fall asleep while using the Deep Zzzs sleep gummy. hours to 6.79

Sleep 95
article thumbnail

Real world data: CBD with CBN, THC, and melatonin is a winning formula for sleep

The Cannigma

So it’s not surprising that products that combine cannabis and melatonin are making their way into legal marketing – and according to real world data gathered in a recent campaign on The Cannigma, it’s a winning combination. What’s in FOCL’s DEEP SLEEP, Full Spectrum+ Gummies? The average level of sleep disturbance was 58.67

Sleep 83
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What is THC-O?

Otherside Farms

THC-O is three times as strong as delta 9 THC and five times as strong as delta 8 THC. Many cannabis fans are interested in THC-O because it is easily absorbed by the body and produces a potent and tranquilizing high. About THC-O. THC-O, is also known as THC-O-acetate. THC-O vs DELTA 9 THC.

THC 98
article thumbnail

Best CBD Gummies For Sleep – How They Work & Which Ones To Buy

Miss Marijuana

Nighttime routines are sacred and essential to a good night’s sleep. . Adding CBD to your nighttime to-do list could help regulate your sleep cycle and improve your overall well-being. . CBD gummies for sleep – Do they work? When you can’t sleep, you may feel irritated, anxious, and sad.

Sleep 59
article thumbnail

Survey Data Reveals Most Common Reasons People Use CBD

SpeedWeed

Stress, anxiety, and quality of sleep. The study, based on survey data and published in the Journal of Cannabis Research, showed “that CBD users take the drug to manage self-perceived anxiety, stress, sleep, and other symptoms, often in low doses, and these patterns vary by demographic characteristics.”. View original article.

Data 52
article thumbnail

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Cannabis Law Report

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. As previously disclosed, IGC submitted IGC-AD1 to the U.S.

article thumbnail

OLCC Finalizes New Rules on Delta-8 THC and other Artificially Derived Cannabinoids

Cannabis Law Report

The Oregon Liquor Control Commission (OLCC) recently finalized new administrative rules on Delta-8 THC and other artificially derived cannabinoids as directed by HB 3000 (2021). These rules do not apply to industrial hemp licensees who legally operate outside of OLCC’s regulated cannabis market – the below rules apply only to OLCC licensees.